» Articles » PMID: 37968556

Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years

Abstract

Background: The presentation of eosinophilic esophagitis (EoE) is heterogeneous, but trends over time are not known.

Aim: To determine whether clinical and endoscopic phenotypes at EoE diagnosis have changed over the past 2 decades.

Methods: In this retrospective cohort study, adults and children with newly diagnosed EoE were phenotyped as follows: (1) inflammatory vs fibrostenotic vs mixed on endoscopy; (2) atopic vs non-atopic; (3) age at symptom onset; (4) age at diagnosis; (5) presence of autoimmune or connective tissue disease; and (6) responsive to steroids. The prevalence of different phenotypes was categorized by 5-year intervals. Multivariate analysis was performed to assess for changes in patient features over time.

Results: Of 1187 EoE patients, age at diagnosis increased over time (from 22.0 years in 2002-2006 to 31.8 years in 2017-2021; p < 0.001) as did the frequency of dysphagia (67% to 92%; p < 0.001). Endoscopic phenotypes were increasingly mixed (26% vs 68%; p < 0.001) and an increasing proportion of patients had later onset of EoE. However, there were no significant trends for concomitant autoimmune/connective tissue disease or steroid responder phenotypes. On multivariate analysis, after accounting for age, dysphagia, and food impaction, the increase in the mixed endoscopic phenotype persisted (aOR 1.51 per each 5-year interval, 95% CI 1.31-1.73).

Conclusion: EoE phenotypes have changed over the past two decades, with increasing age at diagnosis and age at symptom onset. The mixed endoscopic phenotype also increased, even after controlling for age and symptomatology. Whether this reflects changes in provider recognition or disease pathophysiology is yet to be elucidated.

Citing Articles

Histologic Response or Endoscopic Normalization After Initial Treatment for Eosinophilic Esophagitis in Children Leads to Less Fibrostenosis over Long-Term Follow-Up.

Thel H, Borinsky S, LaFata S, Gee T, Cameron B, Xue A Dig Dis Sci. 2025; .

PMID: 39960589 DOI: 10.1007/s10620-025-08914-2.


Development and Validation of the PICK-UP-STRICS Score to Predict Fibrostenosis in Patients with EoE Prior to Endoscopy.

Chang J, LaFata S, Gee T, Redd W, Barlowe T, Cotton C Dig Dis Sci. 2024; 70(1):292-297.

PMID: 39641895 DOI: 10.1007/s10620-024-08777-z.


EoE in the Sunlight: The Contribution of Vitamin D to Disease Presentation and Severity.

Gupta M, Bredenoord A Dig Dis Sci. 2024; 69(4):1090-1092.

PMID: 38183557 DOI: 10.1007/s10620-023-08259-8.

References
1.
Hoofien A, Papadopoulou A, Gutierrez-Junquera C, Martinez Gomez M, Dominguez-Ortega G, Oudshoorn J . Sustained Remission of Eosinophilic Esophagitis Following Discontinuation of Dietary Elimination in Children. Clin Gastroenterol Hepatol. 2019; 18(1):249-251.e1. DOI: 10.1016/j.cgh.2019.03.008. View

2.
Munoz-Osores E, Maldonado-Campos I, Olivares-Labbe M, Villarroel L, Gana J . Corticosteroids for Eosinophilic Esophagitis in Children: A Meta-analysis. Pediatrics. 2020; 146(5). DOI: 10.1542/peds.2020-0874. View

3.
Dellon E, Tsai Y, Coffey A, Bodwin K, Sninsky J, Mosso C . Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis. Dis Esophagus. 2022; 36(4). PMC: 11220672. DOI: 10.1093/dote/doac071. View

4.
Reed C, Corder S, Kim E, Sanders E, Tappata M, Eluri S . Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation. Am J Gastroenterol. 2020; 115(6):853-858. PMC: 7274870. DOI: 10.14309/ajg.0000000000000597. View

5.
Dellon E, Gibbs W, Fritchie K, Rubinas T, Wilson L, Woosley J . Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009; 7(12):1305-13. PMC: 2789852. DOI: 10.1016/j.cgh.2009.08.030. View